HMD
HERAMED LIMITED
$0.0360
▼ -2.70%
Market cap
$42M
Turnover
$15,082
Last price
$0.0360
Day change
-2.70%
Announcements
7
Range, past year
Open 0.039 · Low 0.006 · Now 0.036 · High 0.055
Open HMD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
HMD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
38/100
Wyckoff phase
Accumulation14d
Trend stage
Breakdown
1 Day
-2.7%
1 Week
-14.3%
1 Month
+9.1%
1 Year
-7.7%
RSI
38
Avg daily range
5.5%
HERAMED LIMITED scores 38 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Accumulation, where it has been for 14 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
What stands out
- Volume 2.2× 60-day avg
Points to watch
- 60d drawdown -26.5%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
HMD announcements
Recent price-sensitive releases.
- 2026-09-16 Lee Health Approves Expansion of HeraMED Maternity Program Trading Halt Lifted | Progress Report
- 2026-09-15 Trading Halt Trading Halt
- 2026-08-28 Appendix 4D and Half Year Report Half Yearly Report | Half Year Audit Review | Half Year Directors' Statement | Half Year Accounts | Half Year Directors' Report
- 2026-07-31 Quarterly Activities & Cashflow Report Commitments Test Entity - Second Quarter Activity Report | Commitments Test Entity - Second Quarter Cashflow Report
- 2026-07-14 HeraMED successfully completes Phase 1 pilot with Lee Health
- 2026-04-30 Quarterly Activities & Cashflow Report
More Health Care stocks
Most traded in the same sector.